Имажинария

О себе

Rare disease research typically suffers from near zero funding; the number of patients does not contribute to profits for pharmaceutical companies. BreakingNews reports showcase, and how the best treatments start from university research departments or medical studies funded by government money. Patient advocacy groups spend countless hours trying to raise awareness and funding for conditions that statistically only affect a small number of people globally.